BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aihara Y, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Morioka C, Kaji K, Tastumi H, Nakanishi K, Nakamura M, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Uemura M, Fukui H. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2012; 4(5): 115-118 [PMID: 22645635 DOI: 10.4251/wjgo.v4.i5.115]
URL: https://www.wjgnet.com/1007-9327/full/v4/i5/115.htm
Number Citing Articles
1
Allison E. Berndtson, Michelle G. Hamel, Todd W. Costantini, Raul Coimbra. Acalculous Perforated Hemorrhagic Emphysematous Cholecystitis Caused by Clostridium perfringens in a Patient with Myeloma Taking DaratumumabSurgical Infections Case Reports 2017; 2(1): 1 doi: 10.1089/crsi.2016.0050
2
Leonardo Gomes da Fonseca, Romualdo Barroso-Sousa, Jorge Sabbaga, Paulo Marcelo Hoff. Acute Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with SunitinibClinics and Practice 2014; 4(1): 24 doi: 10.4081/cp.2014.635
3
Thejus T. Jayakrishnan, Ryan T. Groeschl, Ben George, James P. Thomas, Sam Pappas, T. Clark Gamblin, Kiran K. Turaga. Management of acute cholecystitis in cancer patients: a comparative effectiveness approachSurgical Endoscopy 2014; 28(5): 1505 doi: 10.1007/s00464-013-3344-2
4
Shuya Honda, Yoshinori Saito, Koji Sawada, Takumu Hasebe, Shunsuke Nakajima, Toshikatsu Okumura. Repeated Perforation of the Gallbladder in a Patient with Hepatocellular Carcinoma Receiving LenvatinibInternal Medicine 2020; 59(5): 657 doi: 10.2169/internalmedicine.3806-19
5
Kazunaga Ishigaki, Tsuyoshi Hamada, Yousuke Nakai, Yuki Ishigaki, Hiroki Oyama, Sachiko Kanai, Tatsunori Suzuki, Tomoka Nakamura, Tatsuya Sato, Ryunosuke Hakuta, Kei Saito, Tomotaka Saito, Naminatsu Takahara, Suguru Mizuno, Hirofumi Kogure, Ryosuke Tateishi, Minoru Tada, Kazuhiko Koike. Lenvatinib-induced acute acalculous cholecystitis in a patient with hepatocellular carcinomaClinical Journal of Gastroenterology 2020; 13(4): 568 doi: 10.1007/s12328-020-01116-5
6
Thejus T. Jayakrishnan, Ryan T. Groeschl, Ben George, James P. Thomas, T. Clark Gamblin, Kiran K. Turaga. Review of the Impact of Antineoplastic Therapies on the Risk for Cholelithiasis and Acute CholecystitisAnnals of Surgical Oncology 2014; 21(1): 240 doi: 10.1245/s10434-013-3300-3
7
F. Platini, S. Cavalieri, S. Alfieri, C. Bergamini, C. Resteghini, A. Bottiglieri, E. Colombo, L. Mazzeo, L. Licitra, B. Paolini, E. Seregni, L. D. Locati. Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinibEndocrine 2021; 73(3): 641 doi: 10.1007/s12020-021-02702-4
8
Se Woong Choi, Jeong Min Lee, Dong Gyun Kim, Myung Hwan Noh. Acute Acalculous Cholecystitis Associated with Sunitinib Treatment for Renal Cell CarcinomaThe Korean Journal of Gastroenterology 2020; 75(2): 103 doi: 10.4166/kjg.2020.75.2.103
9
Ryo Kurokawa, Shohei Inui, Tomoya Tanishima, Moto Nakaya, Mariko Kurokawa, Masanori Ishida, Wataru Gonoi, Shiori Amemiya, Yousuke Nakai, Kazunaga Ishigaki, Ryosuke Tateishi, Kazuhiko Koike, Osamu Abe. Incidence and computed tomography findings of lenvatinib-induced pancreatobiliary inflammationMedicine 2021; 100(35): e27182 doi: 10.1097/MD.0000000000027182
10
Tomohiro Enokida, Makoto Tahara. Management of VEGFR-Targeted TKI for Thyroid CancerCancers 2021; 13(21): 5536 doi: 10.3390/cancers13215536